RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ROSSI FG
Collezione AOU Novara

Items : 3

Efficacy and safety of bendamustine, rituximab and bortezomib treatment in relapsed/refractory Waldenstrom Macroglobulinaemia: results of phase 2 single-arm FIL-BRB trial. in British journal of haematology / Br J Haematol. 2025 Feb;206(2):556-564. doi: 10.1111/bjh.19920. Epub 2024 Nov 27.

2025
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Freilone R; Varettoni M; Ferrero S; Tani M; Sartori R; Merli M; Pietrantuono G; Musuraca G; Tosi P; Mannina D; Ferrante M; Gaidano G; Caravita di Toritto T; Rossi FG; Califano C; Curreli L; Cavallo F; Conconi A; Boccomini C; Dessi D; Castiglione A; Monaco F; Drandi D; Villivà N; Benevolo G;

Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study. in Leukemia / Leukemia. 2023 Feb;37(2):433-440. doi: 10.1038/s41375-022-01780-1. Epub 2023 Jan 18.

2023
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Pileri SA; Corradini P; Carniti C; Ciccone G; Tucci A; Boccomini C; Bermema A; Magagnoli M; Cavallo F; Leonardi F; Arcaini L; Patti C; Ballerini F; Musuraca G; Bruna R; Benedetti F; Volpetti S; Flenghi L; Celli M; Zilioli VR; Ilariucci F; Arcari A; Rossi FG; Zanni M; Ciancia R; Ghiggi C; Pinto A; Stefoni V; Usai SV; et alii...

Real-world Outcomes of Relapsed/Refractory Diffuse Large B-cell Lymphoma Treated With Polatuzumab Vedotin-based Therapy. in HemaSphere / Hemasphere. 2022 Nov 11;6(12):e798. doi: 10.1097/HS9.0000000000000798. eCollection 2022 Dec.

2022
AOU Novara

Gherlinzoni F; Minoia C; Rossi FG; Lucchini E; Pennese E; Dessi' D; Ferrarini I; Scalzulli PR; Salerno M; Musso M; Nizzoli ME; Flenghi L; Masia F; Tisi MC; Bruna R; Puccini B; Fabbri A; Pellegrini C; Broccoli A; Argnani L; Musto P; Patti C; Stefoni V; Zinzani PL;